CVS Health to hold fourth quarter and full year 2025 earnings conference call
Rhea-AI Summary
CVS Health (NYSE: CVS) will hold a conference call for fourth quarter and full year 2025 financial results on Wednesday, February 11, 2026 at 8:00 a.m. ET.
An audio webcast will be broadcast simultaneously on the company's Investor Relations website at investors.cvshealth.com and will be archived there for one year.
Positive
- None.
Negative
- None.
News Market Reaction – CVS
In the Jan 9 session, CVS declined 0.37%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 06 | Dividend declaration | Positive | +0.3% | Board approved a $0.665 quarterly dividend payable in early February. |
| Dec 11 | Public health initiative | Neutral | +2.4% | Offered MMR vaccines across South Carolina amid a measles outbreak. |
| Dec 09 | Guidance & strategy | Positive | +2.2% | Raised 2025 guidance, issued 2026 outlook, outlined multi-year growth plan. |
| Dec 05 | Economic impact report | Positive | -1.5% | Reported $474B U.S. economic impact and broad national footprint metrics. |
| Dec 04 | Aetna care initiatives | Positive | +2.3% | Expanded prior-authorization simplification and AI-enabled care collaboration. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news has mostly seen price gains, with 4 aligned reactions and 1 divergence; one positive strategic/economic update drew a negative response.
Over the past months, CVS released several notable updates. A $0.665 quarterly dividend for payment on Feb 2, 2026 saw a modest positive reaction. Investor Day on Dec 9, 2025 featured raised 2025 revenue guidance to at least $400.0B and detailed 2026 outlook, which was well received. Operational announcements on measles vaccinations, national economic impact of $474B, and Aetna’s care and AI initiatives also drew mostly positive price responses, framing today’s earnings-call scheduling within a backdrop of active strategic communication.
Key Terms
audio webcast technical
investor relations financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year.
About CVS Health
CVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of September 30, 2025, the Company had approximately 9,000 retail locations, more than 1,000 walk-in and primary care medical clinics, and a leading pharmacy benefits manager with approximately 87 million plan members. The Company also serves an estimated more than 37 million people through traditional, voluntary and consumer-directed health insurance products and related services, including highly rated Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company's integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.
Media contact
Ethan Slavin
860-273-6095
SlavinE@cvshealth.com
Investor contact
Larry McGrath
800-201-0938
investorinfo@cvshealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/cvs-health-to-hold-fourth-quarter-and-full-year-2025-earnings-conference-call-302656819.html
SOURCE CVS Health